Morphology-dependent fluorescence of europium-doped cerium oxide nanomaterials.

Europium-doped CeO2 nanomaterials have been investigated for a variety of sensing and biological applications, as doping enhances the catalytic activity of CeO2 and contributes visible fluorescence to the nanomaterial. However, scant evidence is available that directly compares Eu3+ fluorescence from multiple morphologies establishing useful correlation(s) between physical and optical trends in such structures. To address this shortcoming, Eu3+-doped CeO2 nanorods, nanowires, nanocubes, and annealed nanorods were synthesized and characterized, representing a range of crystalline defect sizes, defect concentrations, and surface moieties. Morphologies rich with oxygen defects and hydroxyl groups (assessed via X-ray photoelectron spectroscopy) quenched the Eu3+ fluorescence, while samples with larger crystalline domains and lower Ce3+ concentrations have relatively stronger emission intensities. Of the four morphologies, nanocubes exhibit the strongest emission, as each structure is monocrystalline with few oxygen defects and associated quenching sites. Furthermore, the Eu3+ hypersensitive transition is more responsive to the dopant concentration in the nanocubes, as defects induced by the dopant are not removed by thermal annealing.

Rare-Earth-Doped Cerium Oxide Nanocubes for Biomedical Near-Infrared and Magnetic Resonance Imaging.

Near-infrared (NIR) fluorescence provides a new avenue for biomedical fluorescence imaging that allows for the tracking of fluorophore through several centimeters of biological tissue. However, such fluorophores are rare and, due to accumulation-derived toxicity, are often restricted from clinical applications. Deep tissue imaging not only provided by near-infrared fluorophores but also conventionally carried out by magnetic resonance imaging (MRI) or computed tomography (CT) is also hampered by the toxicity of the contrast agents. This work offers a biocompatible imaging solution: cerium oxide (CeO2) nanocubes doped with ytterbium or neodymium, and co-doped with gadolinium, showing simultaneous potential for near-infrared (NIR) fluorescence and magnetic resonance imaging (MRI) applications. A synthetic process described in this work allows for the stable incorporation of ytterbium or neodymium, both possessing emissive transitions in the NIR. As a biocompatible nanomaterial, the CeO2 nanocubes act as an ideal host material for doping, minimizing lanthanide fluorescence self-quenching as well as any potential toxicity associated with the dopants. The uptake of nanocubes by HeLa cells maximized at 12 h was monitored by hyperspectral imaging of the ytterbium or neodymium NIR emission, indicating the capacity of the lanthanide-doped nanocubes for in vitro and a potential for in vivo fluorescence imaging. The co-doped nanocubes demonstrate no significant loss of NIR emission intensity upon co-doping with 2 atomic % gadolinium and exhibit magnetic susceptibilities in the range of known negative contrast agents. However, a small increase to 6 atomic % gadolinium significantly affects the magnetic susceptibility ratio (r2/r1), shifting closer to the positive contrast range and suggesting the potential use of the CeO2 nanocube matrix doped with selected rare-earth ions as a tunable MRI contrast agent with NIR imaging capabilities.